TNFSF11 and Fabry disease: While the Prrx-1 inducible model replicates key features of human FD,8,29 there are subtle but relevant differences, including a higher baseline proportion of bone content within fibro-osseous lesions and the inability to use this transgenic model to investigate the effects of RANKL inhibition on the regulation of FD Gαs expression.